ClinicalTrials.Veeva

Menu

Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns

University of Virginia logo

University of Virginia

Status and phase

Completed
Phase 4

Conditions

Burn

Treatments

Drug: silver sulfadiazine
Drug: water-soluble therapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Partial thickness burns are a common, painful injury requiring a great deal of resources in their care. Silver sulfadizine is a commonly-used topical antimicrobial, but is difficult to remove due to its lipid base. We are comparing a water-based topical antimicrobial therapy to silver sulfadiazine and hypothesize that the water-based therapy is superior in terms of pain control and resources required to deliver care.

Enrollment

8 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult inpatients with partial thickness burns

Exclusion criteria

  • superficial or full thickness burns, facial burns, intubated or sedated, pediatric

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

8 participants in 2 patient groups

water-soluble therapy
Experimental group
Description:
The patient acted as their own control and the experimental and comparison arms (water-soluble therapy and silver sulfadiazine) were alternated on a daily basis
Treatment:
Drug: silver sulfadiazine
Drug: water-soluble therapy
silver sulfadiazine
Active Comparator group
Description:
The patient acted as their own control and the experimental and comparison arms (water-soluble therapy and silver sulfadiazine) were alternated on a daily basis
Treatment:
Drug: silver sulfadiazine
Drug: water-soluble therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems